Dr Lantian Lu
Senior Research Assistant
School of Chemistry and Molecular Biosciences
Journal Articles
Zhang, Jiahui, Madge, Harrison Y. R., Mahmoud, Asmaa, Lu, Lantian, Wang, Wanyi, Huang, Wenbin, Koirala, Prashamsa, Gonzalez Cruz, Jazmina L., Kong, Wei Yang, Bashiri, Sahra, Shalash, Ahmed O., Hussein, Waleed M., Khalil, Zeinab G., Wells, James W., Toth, Istvan and Stephenson, Rachel J. (2025). A synthetic cyclic peptide for promoting antigen presentation and immune activation. NPJ Vaccines, 10 (1) 9, 9-1. doi: 10.1038/s41541-024-01050-4
Nahar, Ummey J., Wang, Jingwen, Shalash, Ahmed O., Lu, Lantian, Islam, Md. T., Alharbi, Nedaa, Koirala, Prashamsa, Khalil, Zeinab G., Capon, Robert J., Hussein, Waleed M., Toth, Istvan and Skwarczynski, Mariusz (2024). Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant. Vaccine, 42 (23) 126060. doi: 10.1016/j.vaccine.2024.06.027
Lu, Lantian, Kong, Wei Yang, Zhang, Jiahui, Firdaus, Farrhana, Wells, James W., Stephenson, Rachel J., Toth, Istvan, Skwarczynski, Mariusz and Cruz, Jazmina L. Gonzalez (2024). Utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines in vitro. Frontiers in Immunology, 15 1298721, 1-13. doi: 10.3389/fimmu.2024.1298721
Liu, Liang, Lu, Lantian, Qiu, Min, Han, Ning, Dai, Shijie, Shi, Shuiping, He, Shanshan, Zhang, Jing, Yan, Qingfeng and Chen, Shuqing (2024). Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets. International Wound Journal, 21 (1) e14384. doi: 10.1111/iwj.14384
Firdaus, Farrhana Z., Bartlett, Stacey, Hussein, Waleed M., Lu, Lantian, Wright, Quentin, Huang, Wenbin, Nahar, Ummey J., Yang, Jieru, Khongkow, Mattaka, Veitch, Margaret, Koirala, Prashamsa, Ruktanonchai, Uracha R., Monteiro, Michael J., Gonzalez Cruz, Jazmina L., Stephenson, Rachel J., Wells, James W., Toth, Istvan and Skwarczynski, Mariusz (2023). Liposomal formulations of a polyleucine–antigen conjugate as therapeutic vaccines against cervical cancer. Pharmaceutics, 15 (2) 602, 1-15. doi: 10.3390/pharmaceutics15020602
Koirala, Prashamsa, Chen, Sung‐Po R., Boer, Jennifer C., Khalil, Zeinab G., Deceneux, Cyril, Goodchild, Georgia, Lu, Lantian, Faruck, Mohammad Omer, Shalash, Ahmed O., Bashiri, Sahra, Capon, Robert J., Hussein, Waleed M., Monteiro, Michael J., Plebanski, Magdalena, Toth, Istvan and Skwarczynski, Mariusz (2023). Polymeric nanoparticles as a self‐adjuvanting peptide vaccine delivery system: the role of shape. Advanced Functional Materials, 33 (12) 2209304, 2209304. doi: 10.1002/adfm.202209304
Shou, Jiawei, Mo, Fan, Zhang, Shanshan, Lu, Lantian, Han, Ning, Liu, Liang, Qiu, Min, Li, Hongseng, Han, Weidong, Ma, Dongying, Guo, Xiaojie, Guo, Qianpeng, Huang, Qinxue, Zhang, Xiaomeng, Ye, Shengli, Pan, Hongming, Chen, Shuqing and Fang, Yong (2022). Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy. Frontiers in Immunology, 13 1000681, 1-16. doi: 10.3389/fimmu.2022.1000681
Chen, Zheling, Zhang, Shanshan, Han, Ning, Jiang, Jiahong, Xu, Yunyun, Ma, Dongying, Lu, Lantian, Guo, Xiaojie, Qiu, Min, Huang, Qinxue, Wang, Huimin, Mo, Fan, Chen, Shuqing and Yang, Liu (2021). A neoantigen-based peptide vaccine for patients with advanced pancreatic cancer refractory to standard treatment. Frontiers in Immunology, 12 691605, 1-11. doi: 10.3389/fimmu.2021.691605
Feng, Ye, Jiang, Haiping, Qiu, Min, Liu, Liang, Zou, Shengmei, Li, Yun, Guo, Qianpeng, Han, Ning, Sun, Yingqiang, Wang, Kui, Lu, Lantian, Zhuang, Xinlei, Zhang, Shanshan, Chen, Shuqing and Mo, Fan (2021). Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2. Pathogens, 10 (6) 737, 1-16. doi: 10.3390/pathogens10060737
Lu, Lantian, Duong, Viet Tram, Shalash, Ahmed O., Skwarczynski, Mariusz and Toth, Istvan (2021). Chemical conjugation strategies for the development of protein-based subunit nanovaccines. Vaccines, 9 (6) 563, 1-24. doi: 10.3390/vaccines9060563
Conference Paper
Fang, Yong, Shou, Jiawei, Mo, Fan, Zhang, Shanshan, Lu, Lantian, Han, Ning, Liu, Liang, Qiu, Min, Li, Hongsen, Han, Weidong, Ma, Dongying, Guo, Xiaojie, Guo, Qianpeng, Huang, Qinxue, Zhang, Xiaomeng, Ye, Shengli, Pan, Hongming and Chen, Shuqing (2022). Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy. 2022 ASCO Annual Meeting, Chicago, IL United States, 3-7 June 2022. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2022.40.16_suppl.3151
Thesis
Lu, Lantian (2025). Development of poly(hydrophobic amino acids)-based immunopotentiators for subunit vaccines against infectious diseases. PhD Thesis, School of Chemistry and Molecular Biosciences, The University of Queensland. doi: 10.14264/dbb546f